The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions

doi:10.1016/0166-2236(91)90061-X

Trends in Neurosciences

Volume 14, Issue 11, November 1991, Pages 494-501

https://doi.org/10.1016/0166-2236(91)90061-X Get rights and content

Abstract

Ibotenic acid and kainic acid lesions of the basal forebrain induce profound deficits in performance on a wide variety of tasks involving discrimination learning and memory. These observations have been widely taken to reflect damage of cholinergic projections from the nucleus basalis magnocellularis (NBM) to the neocortex, and to provide an animal model of dementia. However, injections of the toxins quisqualic acid and, more recently, α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) into the same site, which produce at least as extensive cholinergic cell loss, induce only marginal impairments on the same range of cognitive tasks. Further analysis suggests that the cholinergic regulation of the neocortex may influence specific aspects of discrimination learning and visual attention. Conversely, we propose that many of the functional consequences of ibotenic acid lesions on mnemonic tasks cannot be attributed to disruption of basal forebrain cholinergic systems, but may instead result from damage in the globus pallidus to corticostriatal output pathways.

References (99)

J.M. Candy
J. Neurol. Sci.
(1983)
P. Davies et al.
Lancet
(1976)
E.K. Perry et al.
J. Neurol. Sci.
(1977)
G. Smith
Brain Res. Rev.
(1988)
H.C. Fibiger
Trends Neurosci.
(1991)
M.R. Kozlowski et al.
Brain Res.
(1986)
S. Nakamura et al.
Behav. Brain Res.
(1988)
L.E. Jarrard et al.
Pharmacol. Biochem. Behav.
(1984)
S.R. McGurk et al.
Neuroscience
(1987)
Y.S. Allen et al.
Neurosci. Lett.
(1988)

C. Flicker et al.

Pharmacol. Biochem. Behav.

(1983)

M. Miyamoto et al.

Brain Res.

(1985)

D.J. Hepler et al.

Brain Res.

(1985)

E. Friedman et al.

Pharmacol. Biochem. Behav.

(1983)

H.J. Altman et al.

Neurobiol. Aging

(1985)

S.B. Dunnett

Neuroscience

(1985)

V. Haroutunian et al.

Life Sci.

(1985)

R.F. Berman et al.

Pharmacol. Biochem. Behav.

(1988)

J.D. Salamone et al.

Behav. Brain Res.

(1984)

R.J. Beninger et al.

Pharmacol. Biochem. Behav.

(1986)

B. Dubois et al.

Brain Res.

(1985)

B.J. Knowlton et al.

Brain Res.

(1985)

C.L. Murray et al.

Neuroscience

(1985)

I.Q. Whishaw et al.

Behav. Brain Res.

(1985)

R.J. Mandel et al.

Behav. Brain Res.

(1989)

A.C. Santucci et al.

Physiol. Behav.

(1989)

D.F. Wozniak et al.

Neurobiol. Aging

(1989)

T.W. Robbins

Behav. Brain Res.

(1989)

J.L. Evenden

Behav. Brain Res.

(1989)

B.J. Everitt

Neuroscience

(1987)

T.W. Robbins et al.

Neuroscience

(1989)

G. LoConte et al.

Pharmacol. Biochem. Behav.

(1982)

B.J. Hurlbut et al.

Physiol. Behav.

(1987)

S.E. Robinson et al.

Brain Res.

(1988)

R.M. Ridley et al.

Brain Res.

(1986)

V. Haroutunian et al.

Brain Res.

(1989)

V. Haroutunian et al.

Physiol. Behav.

(1990)

H.A. Tilson

Brain Res.

(1988)

S.A. Welner et al.

Brain Res.

(1988)

H. Hodges et al.

Prog. Brain Res.

(1990)

J.D. Sinden et al.

Behav. Brain Res.

(1990)

D.J. Connor et al.

Brain Res.

(1991)

A.L. Markowska et al.

Behav. Neural. Biol.

(1990)

K.J. Page et al.

Neuroscience

(1991)

T. Arendt

Neuroscience

(1989)

S.B. Dunnett et al.

Exp. Neurol.

(1988)

I.Q. Whishaw et al.

Behav. Brain Res.

(1985)

L.E. Annett et al.

Behav. Brain Res.

(1989)

R.J. Sutherland et al.

Behav. Brain Res.

(1990)

Cited by (405)

p-Coumaric acid mitigates passive avoidance memory and hippocampal synaptic plasticity impairments in aluminum chloride-induced Alzheimer's disease rat model
2022, Journal of Functional Foods
The present study was designed to determine the effects of p-coumaric acid (p-CA), a phenolic compound, on passive avoidance memory function and hippocampal long-term potentiation (LTP) in an Alzheimer's disease (AD) rat model induced by aluminum chloride (AlCl₃). p-CA (100 mg/kg; P.O.) was administered concomitantly with AlCl₃ (100 mg/kg; P.O.) for 42 consecutive days. Results of this study revealed an attenuation of memory capacity, which was accompanied by a reduction in both components of LTP (field excitatory postsynaptic potentials slope and population spike amplitude) and an increase in amyloid-beta (Aβ) plaques production in the AlCl₃-exposed rats. Intriguingly, treatment with p-CA improved passive avoidance memory dysfunction, ameliorated hippocampal LTP impairment, and hindered Aβ plaque accumulation in the hippocampal dentate gyrus of AlCl₃-treated rats. This data provides evidence that p-CA improves AlCl₃-induced passive avoidance memory decline, which may be partly related to amelioration of synaptic dysfunction and suppression of Aβ plaque formation.
Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease
2022, NeuroToxicology
The current study elucidates pharmacological evaluation of bromelain as a bioactive compound obtain from pineapple stem belongs to family Bromeliaceae in AlCl₃ and D - galactose induced mice. In mice, co-administration of AlCl₃ at dose 5 mg/kg b.w., via the oral route, and D - galactose at dose 60 mg/kg b.w., via intraperitoneal route for 90 days resulted in cognitive impairment, spatial learning, and memory deficits, as well as neurotoxicity. However, 30 consecutive days, treatments via an intraperitoneal route with bromelain low dose (Brm L) at dose 10 mg/kg b.w., bromelain high dose (Brm H) at dose 20 mg/kg b.w., donepezil (Dnpz) at dose 2 mg/kg b.w., and Brm L + Dnpz at doses 10, 2 mg/kg b.w. were considerably reversed the effect of AlCl₃ and D - galactose induced AD mice. Consequences of behavioral parameters (Morris water maze, elevated plus maze and locomotor), biochemical estimation (MDA, GSH, SOD, CAT, Nitrite and AChE), and ELISA tests (mouse BACE, Aβ_{1 – 42}, TNF-α, IL-6, and BDNF) confirmed significant (p < 0.05) neuroprotective effect of treatments in AlCl₃ and D - galactose induced mice. Additionally, hematoxylin and eosin staining of the cerebral cortex and the hippocampus exposed eosinophilic lesions and hyperchromatic nuclei in AD mice, but these neurodegenerative effects were eliminated by Brm L, Brm H, Dnpz, and Brm L + Dnpz treatments. Thus, bromelain alone and in combination with donepezil prevent AlCl₃ and D - galactose induced spatial learning and memory deficits, as well as cognitive impairment, by increasing cholinergic activity and synaptic plasticity, as well as reducing oxidative damage, neuroinflammation, Aβ _1–42 aggregations, and histopathological damage, according to our findings. The present study consequences indicate that bromelain alone and in combination with donepezil appears to have neuroprotective properties. Henceforward, this may be a promising treatment option for Alzheimer’s disease.
Wheat embryo globulin nutrients ameliorate D-galactose and aluminum chloride-induced cognitive impairment in rats
2021, Brain Research
Wheat embryo globulin nutrient (WEGN), with wheat embryo globulin (WEG) as the main functional component, is a nutritional combination that specifically targets memory impairment. In this study, we explored the protective role of WEGN on Alzheimer's disease (AD)-triggered cognitive impairment, neuronal injury, oxidative stress, and acetylcholine system disorder. Specifically, we established an AD model via administration of d-galactose (d-gal) and Aluminum chloride (AlCl₃) for 70 days, then on the 36th day, administered animals in the donepezil and WEGN (300, 600, and 900 mg/kg) groups with drugs by gavage for 35 days. Learning and memory ability of the treated rats was tested using the Morris water maze (MWM) and novel object recognition (NOR) test, while pathological changes and neuronal death in their hippocampus CA1 were detected via HE staining and Nissl staining. Moreover, we determined antioxidant enzymes by measuring levels of superoxide dismutase (SOD), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px) in serum, cortex, and hippocampus, whereas changes in the acetylcholine system were determined by evaluating choline acetyltransferase (ChAT), and acetylcholinesterase (AChE) activities, as well as choline acetylcholine (Ach) content. Results revealed that rats in the WEGN group exhibited significantly lower escape latency, as well as a significantly higher number of targeted crossings and longer residence times in the target quadrant, relative to those in the model group. Notably, rats in the WEGN group spent more time exploring new objects and exhibited lower damage to their hippocampus neuron, had improved learning and memory activity, as well as reversed histological alterations, relative to those in the model group. Meanwhile, biochemical examinations revealed that rats in the WEGN group had significantly lower MDA levels and AChE activities, but significantly higher GSH, SOD, and ChAT activities, as well as Ach content, relative to those in the model group. Overall, these findings indicate that WEGN exerts protective effects on cognitive impairment, neuronal damage, oxidative stress, and choline function in AD rats treated by d-gal/AlCl₃.
Protective effects of chondroitin sulphate nano-selenium on a mouse model of Alzheimer's disease
2020, International Journal of Biological Macromolecules
In this study, the effect of chondroitin sulphate nano-selenium (CS@Se) on Alzheimer's disease (AD) in mice was investigated. CS@Se alleviated anxiety and improved the spatial learning and memory impairment in AD mice. CS@Se significantly reduced cell oedema and pyknosis, protected the mitochondria, and improved abnormal changes in the ultrastructure of hippocampal neuron synapses of AD mice. Moreover, CS@Se significantly increased the levels of superoxide dismutase(SOD), glutathione peroxidase (GSH-Px), Na⁺/K⁺-ATPase assay (Na⁺/K⁺-ATPase) and acetyltransferase (ChAT), and decreased the levels of malondialdehyde (MDA) and acetylcholinesterase (ChAE) in AD mice. Western blot results showed that CS@Se can attenuate excessive phosphorylation of tau (Ser396/Ser404) by regulating the expression of glycogen synthase kinase-3 beta (GSK-3β). In addition, CS@Se can activate the extracellular signal-regulated kinase 1/2 (ERK 1/2) and p38 mitogen-activated protein kinase (p38 MAPK) signalling pathways to inhibit nuclear transcription factor kappa B (NF-κB) nuclear translocation, thereby regulating the expression of pro-inflammatory cytokines. In summary, CS@Se can reduce oxidative stress damage, inhibit excessive tau phosphorylation, reduce inflammation to delay AD development, and increase the learning and memory capacities of AD mice.
Betulinic acid, a natural PDE inhibitor restores hippocampal cAMP/cGMP and BDNF, improve cerebral blood flow and recover memory deficits in permanent BCCAO induced vascular dementia in rats
2018, European Journal of Pharmacology
Vascular dementia (VaD) is the second most common form of senile dementia, embraces memory deficits, neuroinflammation, executive function damage, mood and behavioral changes and abnormal cerebral blood flow. The purpose of the study was to explore the therapeutic potential of betulinic acid in bilateral common carotid artery occlusion (BCCAO) induced VaD in experimental rats. VaD was induced by BCCAO in rats and betulinic acid (10 and 15 mg/kg/day po) was administered 1 week after surgery. The cerebral blood pressure of the animal was recorded before and after the treatment using Laser Doppler flow meter. Object recognition task for non-spatial, Morris water maze for spatial and locomotor activity was performed to evaluate behavioral changes in rats. At the end of the study, animals were decapitated and hippocampus was separated to perform biochemical, neuroinflammatory and second messengers cAMP/cGMP analysis. Histology was done to study the brain pathophysiology. BCCAO surgery was able to significantly impaired memory in rats as observed behavioral and biochemical parameters. Moreover, BA demonstrated a neuroprotective effect in a dose-dependent manner. BA was able to re-establish cerebral blood flow, restore behavioral parameters and showed significant improvements in the as cAMP,cGMP and BDNF levels, restrain the oxidative stress and inflammatory parameters. In histopathology, betulinic acid treated groups showed a decrease in microgliosis and less pathological abnormalities comparable to diseased rat's brain. The observed effect might be attributed to the neuroprotective potential of betulinic acid and its ability to restore cognitive impairment and hippocampal neurochemistry in VaD.
D-galactose and aluminium chloride induced rat model with cognitive impairments
2018, Biomedicine and Pharmacotherapy
Citation Excerpt :
The co-administration of D-gal and AlCl3 showed cognitive impairments in all the model groups but was more pronounced in Gp2 and Gp3 animals. Acetylcholine (ACh), a cholinergic neurotransmitter important for learning and memory [38–40]. AChE is a marker for loss of cholinergic neurons in the brain because it is the chief enzyme for breaking down of ACh in the synaptic cleft [42,20].
Cognitive impairments and cholinergic dysfunctions have been well reported in old age disorders including Alzheimer’s disease (AD). d-galactose (D-gal) has been reported as a senescence agent while aluminium act as a neurotoxic metal, but little is known about their combined effects at different doses. The aim of this study was to establish an animal model with cognitive impairments by comparing the effects of different doses of co-administrated D-gal and aluminium chloride (AlCl₃). In this study male albino wistar rats were administered with D-gal 60 mg/kg.bwt intra peritoneally (I.P) injected and AlCl₃ (100, 200, or 300 mg/kg.bwt.) was orally administered once daily for 10 consecutive weeks. Performance of the rats were evaluated through behavioural assessments; Morris water maze (MWM) and open field tests (OFT); histopathological examination was performed on the hippocampus; moreover biochemical measurements of acetylcholinesterase (AChE) and hyperphosphorylated tau protein (p-tau) were examined. The results of this experiment on rats treated with D-gal 60 + AlCl₃ 200 mg/kg.bwt showed near ideal cognitive impairments. The rats exhibited an obvious memory and learning deficits, marked neuronal loss in hippocampus, showed increase in AChE activities and high expression of p-tau within the tissues of the brain. This study concludes that D-gal 60 + AlCl₃ 200 mg/kg.bwt as the ideal dose for mimicking AD like cognitive impairments in albino wistar rats. It is also crucial to understand the pathogenesis of this neurodegenerative disease and for drug discovery.

View all citing articles on Scopus

View full text

Trends in Neurosciences

ReviewThe basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions

Abstract

J. Neurol. Sci.

Lancet

J. Neurol. Sci.

Brain Res. Rev.

Trends Neurosci.

Brain Res.

Behav. Brain Res.

Pharmacol. Biochem. Behav.

Neuroscience

Neurosci. Lett.

Pharmacol. Biochem. Behav.

Brain Res.

Brain Res.

Pharmacol. Biochem. Behav.

Neurobiol. Aging

Neuroscience

Life Sci.

Pharmacol. Biochem. Behav.

Behav. Brain Res.

Pharmacol. Biochem. Behav.

Brain Res.

Brain Res.

Neuroscience

Behav. Brain Res.

Behav. Brain Res.

Physiol. Behav.

Neurobiol. Aging

Behav. Brain Res.

Behav. Brain Res.

Neuroscience

Neuroscience

Pharmacol. Biochem. Behav.

Physiol. Behav.

Brain Res.

Brain Res.

Brain Res.

Physiol. Behav.

Brain Res.

Brain Res.

Prog. Brain Res.

Behav. Brain Res.

Brain Res.

Behav. Neural. Biol.

Neuroscience

Neuroscience

Exp. Neurol.

Behav. Brain Res.

Behav. Brain Res.

Behav. Brain Res.

Review
The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions